To study the anti-tumor efficacy of Vam6+/− iNKT in vivo, we transferred expanded Vam6+/− iNKT cell, expanded Vam6+/+ iNKT cells, and PBS into wide-type mice bearing subcutaneous B16F10 tumor cells, respectively (Figure 7A). The gene discussed is VPS39; the disease is neoplasm.